Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD 0.0340
+0.0010 (3.03%)
Sep 18, 2026, 3:59 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 190.01 million as of September 18, 2026. Its market cap has decreased by -15.00% in one year.
Market Cap
190.01M
Enterprise Value
220.24M
Revenue
845.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 190.01M, a decrease of -73.59%. That is a compound annual growth rate of -8.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 190.01M | 17.24% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 712.49M |
| Zhongzhi Pharmaceutical Holdings | 621.79M |
| Fusen Pharmaceutical Company | 613.62M |
| Wai Yuen Tong Medicine Holdings | 384.46M |
| Regent Pacific Group | 261.18M |
| Tianda Pharmaceuticals | 258.01M |
| Extrawell Pharmaceutical Holdings | 243.60M |
| Shenzhen Neptunus Interlong Bio-technique Company | 167.80M |